Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pavitra Kannan

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Journal of Natural Products|January 31, 2006
Synthetic studies of neoclerodane diterpenes from Salvia divinorum: semisynthesis of salvinicins A and B and other chemical transformations of salvinorin AWayne W Harding, Matthew Schmidt, Kevin Tidgewell, et al.
Scientific Reports|March 21, 2023
MDM2 inhibitors, nutlin-3a and navtemadelin, retain efficacy in human and mouse cancer cells cultured in hypoxiaAda Lerma Clavero, Paula Lafqvist Boqvist, Katrine Ingelshed, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 23, 2008
Radiodefluorination of 3-fluoro-5-(2-(2-[18F](fluoromethyl)-thiazol-4-yl)ethynyl)benzonitrile ([18F]SP203), a radioligand for imaging brain metabotropic glutamate subtype-5 receptors with positron emission tomography, occurs by glutathionylation in rat brainH Umesha Shetty, Sami S Zoghbi, Fabrice G Siméon, et al.
ACS Chemical Neuroscience|July 11, 2012
The "specific" P-glycoprotein inhibitor Tariquidar is also a substrate and an inhibitor for breast cancer resistance protein (BCRP/ABCG2)Pavitra Kannan, Sanjay Telu, Suneet Shukla, et al.
Iscience|May 24, 2024
MDM2/MDMX inhibition by Sulanemadlin synergizes with anti-Programmed Death 1 immunotherapy in wild-type p53 tumorsKatrine Ingelshed, Marit M Melssen, Pavitra Kannan, et al.
Communications Biology|January 5, 2021
Reciprocal interactions between tumour cell populations enhance growth and reduce radiation sensitivity in prostate cancerMarcin Paczkowski, Warren W Kretzschmar, Bostjan Markelc, et al.
Journal of Medicinal Chemistry|June 11, 2011
Collateral sensitivity of multidrug-resistant cells to the orphan drug tioproninAndrew S Goldsborough, Misty D Handley, Andrés E Dulcey, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 15, 2015
Tariquidar Is an Inhibitor and Not a Substrate of Human and Mouse P-glycoproteinLora D Weidner, King Leung Fung, Pavitra Kannan, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 5, 2016
An automated method measures variability in P-glycoprotein and ABCG2 densities across brain regions and brain matterPavitra Kannan, Martin Schain, Warren W Kretzschmar, et al.
Journal of Natural Products|June 24, 2006
Synthesis of salvinorin A analogues as opioid receptor probesKevin Tidgewell, Wayne W Harding, Anthony Lozama, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Journal of Natural Products|January 31, 2006
Synthetic studies of neoclerodane diterpenes from Salvia divinorum: semisynthesis of salvinicins A and B and other chemical transformations of salvinorin AWayne W Harding, Matthew Schmidt, Kevin Tidgewell, et al.
Scientific Reports|March 21, 2023
MDM2 inhibitors, nutlin-3a and navtemadelin, retain efficacy in human and mouse cancer cells cultured in hypoxiaAda Lerma Clavero, Paula Lafqvist Boqvist, Katrine Ingelshed, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 23, 2008
Radiodefluorination of 3-fluoro-5-(2-(2-[18F](fluoromethyl)-thiazol-4-yl)ethynyl)benzonitrile ([18F]SP203), a radioligand for imaging brain metabotropic glutamate subtype-5 receptors with positron emission tomography, occurs by glutathionylation in rat brainH Umesha Shetty, Sami S Zoghbi, Fabrice G Siméon, et al.
ACS Chemical Neuroscience|July 11, 2012
The "specific" P-glycoprotein inhibitor Tariquidar is also a substrate and an inhibitor for breast cancer resistance protein (BCRP/ABCG2)Pavitra Kannan, Sanjay Telu, Suneet Shukla, et al.
Iscience|May 24, 2024
MDM2/MDMX inhibition by Sulanemadlin synergizes with anti-Programmed Death 1 immunotherapy in wild-type p53 tumorsKatrine Ingelshed, Marit M Melssen, Pavitra Kannan, et al.
Communications Biology|January 5, 2021
Reciprocal interactions between tumour cell populations enhance growth and reduce radiation sensitivity in prostate cancerMarcin Paczkowski, Warren W Kretzschmar, Bostjan Markelc, et al.
Journal of Medicinal Chemistry|June 11, 2011
Collateral sensitivity of multidrug-resistant cells to the orphan drug tioproninAndrew S Goldsborough, Misty D Handley, Andrés E Dulcey, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 15, 2015
Tariquidar Is an Inhibitor and Not a Substrate of Human and Mouse P-glycoproteinLora D Weidner, King Leung Fung, Pavitra Kannan, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 5, 2016
An automated method measures variability in P-glycoprotein and ABCG2 densities across brain regions and brain matterPavitra Kannan, Martin Schain, Warren W Kretzschmar, et al.
Journal of Natural Products|June 24, 2006
Synthesis of salvinorin A analogues as opioid receptor probesKevin Tidgewell, Wayne W Harding, Anthony Lozama, et al.
Pageof 3